This collaborative research project encompasses several studies focused on HIV drug resistance among patients receiving antiretroviral therapy. The work involves genotypic resistance testing to identify mutations associated with resistance to different classes of antiretroviral drugs targeting the integrase gene among patients with DTG failure. The findings support treatment optimization, surveillance of resistance patterns, and evidence-based policy formulation.
Expected impact: Evidence to inform HIV treatment guidelines for individuals with DTG resistance.
